Pulmatrix, Inc. (PULM) Financials

PULM Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 3.2 million 689000
March 31, 2026 4.5 million 905000
Dec. 31, 2025 4.1 million 329000
Sept. 30, 2025 5.0 million 249000

PULM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -1.1 million 2000
March 31, 2026 -1.1 million 3000
Dec. 31, 2025 -706000 5000
Sept. 30, 2025 -1.0 million 6000

PULM Net Income

No data available :(

PULM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 2.2 million - -
March 31, 2026 3.3 million - -
Dec. 31, 2025 4.1 million - -
Sept. 30, 2025 4.8 million - -

PULM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 3.7 million
March 31, 2026 3.7 million
Dec. 31, 2025 3.7 million
Sept. 30, 2025 3.7 million

PULM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 2000 1.0 million -
March 31, 2026 - 3000 1.3 million -
Dec. 31, 2025 - 3000 911000 -
Sept. 30, 2025 - 8000 858000 -

PULM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - 38000
Sept. 30, 2025 - -

PULM Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PULM

Price: $1.52

52 week price:
1.16
5.58

Earnings Per Share: -1.10 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 23200

Ebitda: -4.2 million

Market Capitalization: 5.7 million

Links: